This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Humana (HUM) Q1 Earnings Beat on Growing Membership & Premiums
by Zacks Equity Research
Humana (HUM) expects adjusted EPS to be at least $28.25 in 2023, up from the previous guidance of $28 per share.
Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PFM
HCA Healthcare (HCA) Beats on Q1 Earnings, Ups '23 EPS View
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter results gain from increased patient admissions. Management expects EPS within the $17.25-$18.55 band this year, higher than the previous view of $16.40-$17.60.
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UnitedHealth's Solid Q1 Earnings Put These ETFs in Focus
by Sweta Killa
UnitedHealth Group reported better-than-expected first-quarter 2023 results, breezing past the Zacks Consensus Estimate for earnings and revenues.
Stock Market News for Apr 17, 2023
by Zacks Equity Research
U.S. stocks ended lower on Friday as investors assessed a batch of mixed economic data and hawkish comments from a Fed official that hinted at another interest rate hike, dampening spirits at the start of the first-quarter earnings season.
UnitedHealth (UNH) Beats on Q1 Earnings, Ups EPS 2023 View
by Zacks Equity Research
Strong membership growth and consistent management of medical and operating costs aid UnitedHealth's (UNH) UnitedHealthcare unit in the first quarter.
UnitedHealth (UNH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for UnitedHealth (UNH) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
UnitedHealth Group (UNH) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 0.32% and 2.92%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
UnitedHealth (UNH) Buys Crystal Run to Boost Value-Based Care
by Zacks Equity Research
UnitedHealth Group (UNH) acquires Crystal Run, as per multiple reports. The move tends to offer enhanced value-based care across the Hudson Valley and lower Catskill region.
Will Q1 Earnings Fuel a Rally in Dow ETF?
by Sweta Killa
As the index is closely tied to the cyclical sectors, the banking turmoil hit hard the Dow last month. Recession fears have added to the woes.
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VIG
3 Quarterly Reports Investors Can't Ignore This Week
by Derek Lewis
Q4 2022 earnings season turned out to be better than feared, helping inject positive sentiment into the market. With the Q1 2023 cycle just around the corner, could investors be in for another surprise?
UnitedHealth's (UNH) UnitedHealthcare Unit to Drive Q1 Earnings
by Zacks Equity Research
An increase in the total number of people served in commercial domestic business of UnitedHealth (UNH) is likely to have boosted its first-quarter performance.
Is SPDR MSCI USA StrategicFactors ETF (QUS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QUS
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $515.18 in the latest trading session, marking a +0.46% move from the prior day.
UnitedHealth (UNH) to Post Q1 Earnings: What You Should Expect
by Zacks Equity Research
UnitedHealth's (UNH) first-quarter results are likely to reflect growing premiums and memberships.
Zacks Investment Ideas feature highlights: Nvidia, United Healthcare, Merck, Pfizer and Intuitive Surgical
by Zacks Equity Research
Nvidia, United Healthcare, Merck, Pfizer and Intuitive Surgical are part of the Zacks Investment Ideas article.
UnitedHealth Group (UNH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons to Buy Healthcare Stocks in the Current Market Environment
by Andrew Rocco
Healthcare stocks are currently providing investors with an attractive way to counterbalance a portfolio overexposed to tech. In general, healthcare stocks have lower betas, are more defensive, and have cleaner balance sheets.
If You Invested $1000 in UnitedHealth Group a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
UnitedHealth Group (UNH) Stock Moves -0.19%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $493.25 in the latest trading session, marking a -0.19% move from the prior day.
Company News for Apr 4, 2023
by Zacks Equity Research
Companies In The Are: TSLA, UBS, UNH, SAIC.
Here's What Makes UnitedHealth Group (UNH) a Lucrative Bet Now
by Zacks Equity Research
UnitedHealth Group (UNH) is well-poised for growth on the back of a growing customer base within its government businesses, efficient telehealth services and solid cash-generating abilities.